Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Informed consent; (2) Patients with clinical diagnosis of colon cancer and radical colorectal cancer by colonoscopy and pathological examination; (3) Patients in good general condition, aged 18-70 years, without serious heart, lung, kidney, liver dysfunction or metabolic diseases; (4) No distant metastatic lesions; (5) No serious complications before surgery and no radiotherapy or chemotherapy. (1) Informed consent; (2) Patients with clinical diagnosis of colon cancer and radical colorectal cancer by colonoscopy and pathological examination; (3) Patients in good general condition, aged 18-70 years, without serious heart, lung, kidney, liver dysfunction or metabolic diseases; (4) No distant metastatic lesions; (5) No serious complications before surgery and no radiotherapy or chemotherapy.
Exclusion criteria
Exclusion criteria: (1) have used various antibiotics or probiotics 1 week before specimen collection; (2) have their gastrointestinal tract and other digestive system diseases; (3) have metabolic diseases, such as obesity, diabetes, various liver diseases, etc.; (4) have family aggregated cases. (1) have used various antibiotics or probiotics 1 week before specimen collection; (2) have their gastrointestinal tract and other digestive system diseases; (3) have metabolic diseases, such as obesity, diabetes, various liver diseases, etc.; (4) have family aggregated cases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fecal high-throughput sequencing;Fecal Metabolomics;immunomics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine;liver function;Electrolyte;Kidney function; | — |
Countries
China
Contacts
Second Affiliated Hospital of Nanchang University